Skip to main content
Equibles
STXS logo

STXS · Stereotaxis, Inc. · Metrics

Track STXS — free

Use STXS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research STXS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.91 -0.06 (-6.21%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$96.93M
Shares
100.20M
Volume · Oct 29 810.41K Avg daily vol (3M) 579.18K

STXS metrics

77 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.91
Market cap
$96.93M

Price action

20 metrics
Price change (1W)
-2.5%
Price change (30D)
-22.4%
Price change (3M)
-27.0%
Price change (6M)
-46.7%
Price change (YTD)
-57.8%
Price change (1Y)
-67.3%
Trailing year
Price change (5Y)
-83.4%
52-week high
$2.97
52-week low
$0.97
Change from 52-week high
-67.3%
Change from 52-week low
+0.0%
Annualized volatility
51.1%
Annualized volatility (3M)
45.4%
Beta
1.7
RSI (14D)
28.9
Price vs SMA 50
-21.8%
Price vs SMA 200
-43.8%
Avg volume (3M)
576,839
Relative volume
0.5
Average dollar volume
$734,115

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
100.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.4×
reciprocal yield 29.8%
P / book
8.3
reciprocal yield 12.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-22.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.1×
reciprocal yield 19.5%
EV / revenue historical average (5Y)
7.6×
reciprocal yield 13.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
55.6%
Operating margin
-75.7%
Trailing 12 months
Net margin
-74.2%
Gross profit (TTM)
$16.71M
Operating profit (TTM)
−$22.75M
Net income (TTM)
−$22.32M
Trailing 12 months
Diluted EPS (TTM)
$-0.24
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.31
Gross profit per diluted share (TTM)
$0.17
Operating profit per diluted share (TTM)
$-0.24
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.23
Operating cash flow per diluted share (TTM)
$-0.16
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.10
Stock compensation per diluted share (TTM)
$0.09
Book value per share
$-2.34

Growth

11 metrics
Revenue growth YoY
-12.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$30.07M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+13.7%
Year over year · more shares
Revenue CAGR (3Y)
+4.8%
Revenue CAGR (5Y)
+4.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-182.3%
Return on assets
-40.2%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$10.49M
Total assets
$55.58M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$15.29M
Capital expenditures (TTM)
$213,000
R&D (TTM)
$10.04M
SG&A (TTM)
—
Stock compensation (TTM)
$8.67M
R&D / revenue
33.4%
Stock compensation / revenue
28.8%

Ownership (13F)

9 metrics
13F filers
108
13F filer change QoQ
-9
Institutional ownership
43.0%
Conviction holders (share of 13F filers)
2.8%
Crowding (high-turnover and private-fund holders)
21.1%
Private-fund adviser ownership
20.0%
Active holders' share change QoQ
-2.4%
Holder tenure
18.9
Price vs estimated holder cost
-21.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
8.0%

Short interest

3 metrics
Short interest
6.0%
Latest settlement · 10.2 days to cover
Days to cover
10.2d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1289340 CUSIP 85916J409 13F (30d) 18 filings 18 filers Visit website Investor relations